1. Introduction {#sec1}
===============

Schiff bases contains azomethine (-C=N-) linkage and are usually derived by the condensation of carbonyl compounds (aldehydes/ketones) with primary aliphatic/aromatic/heteroaromatic amines. Schiff bases are known for their antitumor \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8]\], antifungal \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib13]\], antiviral \[[@bib14]\], antibacterial \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib15], [@bib16], [@bib17]\] and anticancer \[[@bib18], [@bib19]\] activities. Schiff bases find many applications including acid catalyst \[[@bib20], [@bib21], [@bib22], [@bib23]\], reduction catalyst \[[@bib24], [@bib25]\], oxidation catalyst \[[@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31]\], dye \[[@bib32], [@bib33]\] and it also exhibit special liability towards metal ions \[[@bib34], [@bib35], [@bib36], [@bib37]\]. The intermolecular hydrogen bonding ability and proton transfer equilibria of Schiff bases offer them excellent bioactivity \[[@bib38]\]. Metal complexes derived from Schiff bases have been used as insecticides, pesticides, bactericides and fungicides \[[@bib39], [@bib40]\]. Furthermore, metal complexes of Schiff bases harbouring hetero atoms such as N, S, O etc. exhibit several bio potencies \[[@bib41]\] including antitumor \[[@bib42], [@bib43]\], antioxidant \[[@bib44]\], antibacterial \[[@bib45], [@bib46]\], antimalerial \[[@bib47]\] antifungal \[[@bib48]\], anticancer \[[@bib49], [@bib50], [@bib51]\], antiviral \[[@bib52]\], anti-inflammatory \[[@bib53]\] and anti-HIV \[[@bib54]\] activities. Infections with Gram-negative bacteria are especially worrisome than that of Gram-positive bacteria \[[@bib55]\]. Considering the magnitude of ever-growing antibacterial resistance, it is necessary to discover novel Schiff bases with resistance improved pharmacological profile. We chose to synthesize a library of Schiff bases from 1-hydroxy-2-acetonapthanone and diamines having 3-carbon spacer since it offers tetradentate and flexible nature to the new Schiff bases \[[@bib56], [@bib57], [@bib58], [@bib59], [@bib60]\].

In present work, we report here in synthesis, characterization, antibacterial and antioxidant activity of four new Schiff bases derived from 1-(1-hydroxynaphthalen-2-yl)ethanone, 1-(4-chloro-1hydroxynaphthalen-2-yl)ethanone and 1-(4-bromo-1-hydroxynaphthalen-2-yl)ethanone with propane-1,3-diamine and pentane-1,3-diamine. The structures of these Schiffs bases were confirmed by UV, FT-IR, ^1^H-NMR, ^13^C NMR, and Mass spectroscopic tools, and additionally by Elemental analysis.

2. Experimental {#sec2}
===============

Chemicals were obtained from AURA, SPECTROCHEM & TCI and were used as received without any further purification.

2.1. Synthesis {#sec2.1}
--------------

The tetradentate Schiff base, 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol) **(I)** and 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol) **(II)** were synthesized as 1:2 M ratio by the refluxing propane-1,3-diamine (10 mmol) with 1-(1-hydroxynaphthalen-2-yl)ethanone (20 mmol) and 1-(4-chloro-1hydroxynaphthalen-2-yl)ethanone (20 mmol) respectively, also the tetradentate Schiff base, 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol) **(III)** and 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol) **(IV)** were synthesized by the refluxing pentane-1,3-diamine (10 mmol) with 1-(1-hydroxynaphthalen-2-yl)ethanone (20 mmol) and 1-(4-bromo-1-hydroxynaphthalen-2-yl)ethanone (20 mmol). In each reaction 2--3 drops of acetic acid added and absolute ethanol (10 ml) was used as a solvent, the reaction mixture was refluxed for 2--3 h. After completion of heating, reaction mixture was cooled for overnight, the Product was filtered, washed with water and recrystallized with absolute ethanol. The purity of the product was checked by TLC and melting point.

### *2.1.1*. 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1- ol) **(I)** Yield 307.7 mg, 78 %, colour - Yellow, M.P. 153--155 °C {#sec2.1.1}

**FT-IR (KBr, cm**^**−1**^**):** 3485(νOH), 1726(νC = N), 1587(νN−H), 1552(νC = C), 1022(νC−N--C).

^**1**^**H NMR (CDCl**~**3**~**) (ppm) δ:** 13.52(s,Ar-OH,2H), 8.50 (d,J = 7.4Hz,2H), 7.61 (d,J = 7.3Hz,2H), 7.55(dd, J = 4.8Hz,J = 1.4Hz,2H), 7.50(dd,J = 5.4,J = 2.1Hz,2H), 7.40(dd,J = 7.3Hz,J = 1.3Hz,2H), 6.85(dd, J = 6.3Hz,J = 4.7Hz,2H), 3.83(t,J = 4.6Hz,-CH~2~,4H), 2.47(s,-CH~3,~6H), 2.40--2.31(m,J = 4.6Hz,-CH~2,~2H).

^**13**^**C NMR (CDCl**~**3**~**) (ppm) δ:** 175.2(−[C]{.ul}=N−), 171.6([C]{.ul}--O), 137.2--108.8(Ar-[C]{.ul}-), 42.2(−N--[C]{.ul}H~2~-), 29.4(HC--[C]{.ul}--CH~2~-), 14.5(-N=C--[C]{.ul}H~3~).

ESIMS (*m/z*): 411.20 (29.2 %).

### *2.1.2*. 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4- chloronaphthalen-1-ol) (**II)** Yield 328.9 mg, 72 %, colour - Brown, M.P. 158--160 °C {#sec2.1.2}

**FT-IR (KBr, cm**^**−1**^**):** 3399(νOH), 1724(νC = N), 1585(νN−H), 1525(νC = C), 1072(νC−N--C).

^**1**^**H NMR (CDCl**~**3**~**) (ppm) δ:** 14.02(s,Ar-OH,2H), 8.53(dd,J = 7.3Hz,J = 1.0Hz,2H), 7.77(dd, J = 5.3Hz,J = 3.1Hz,2H), 7.67(dd,J = 6.3Hz,J = 1.2Hz,2H), 7.26 (s,2H), 6.84(dd,J = 6.9Hz,J = 3.6Hz,2H), 3.84(t,J = 4.5Hz,-CH~2~,4H), 2.50(s,-CH~3,~6H), 2.40--2.33(m,J = 4.5Hz,-CH~2,~2H).

^**13**^**C NMR (CDCl**~**3**~**) (ppm) δ:** 175.2(−[C]{.ul}=N−), 171.7([C]{.ul}--O), 137.1--108.2(Ar-[C]{.ul}-), 132.4(-[C]{.ul}-X), 42.1(−N--[C]{.ul}H~2~-), 29.2(HC--[C]{.ul}--CH~2~-), 14.4(-N=C--[C]{.ul}H~3~).

ESIMS (*m/z*): 480.12 (63.9 %)

### *2.1.3*. 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol) **(III)** Yield 298.6 mg, 75 %, colour - Yellow, M.P. 172--174 °C {#sec2.1.3}

**FT-IR (KBr, cm**^**−1**^**):** 3485(νOH), 1725(νC = N), 1593(νN−H), 1562(νC = C),1022(νC−N--C).

^**1**^**H NMR (CDCl**~**3**~**) (ppm) δ:** 13.50(s,Ar-OH,2H), 8.50 (d,J = 7.6Hz,2H), 7.61 (d,J = 7.2Hz,2H), 7.50 (dd, J = 4.6Hz,J = 1.2Hz,2H), 7.46(dd,J = 5.3Hz,J = 1.4Hz,2H), 7.26(dd,J = 7.3Hz,J = 1.3Hz,2H), 6.80(dd, J = 7.3Hz,J = 4.7Hz,2H), 4.32(t,J = 4.6Hz,-CH~2~,2H), 3.71--3.69(m,J = 4.6Hz,-CH~,~1H), 2.44(s,-CH~3,~3H), 2.40(s,-CH~3~,3H), 2.21(q,J = 4.3Hz,-CH~2,~2H), 1.86--1.82(m,J = 4.1Hz,-CH~2,~2H), 1.02(t,J = 4.1Hz,-CH~3,~3H).

^**13**^**C NMR (CDCl**~**3**~**) (ppm) δ:** 175.2(−[C]{.ul}=N−), 171.1([C]{.ul}--O), 137.2--106.5(Ar-[C]{.ul}-), 54.1(-N-[C]{.ul}-H), 41.8(−N--[C]{.ul}H~2~-), 34.6(HC--[C]{.ul}--CH~2~-), 29.4(H~3~C--[C]{.ul}--CH-), 14.4(-N=C--[C]{.ul}H~3~), 10.3(-[C]{.ul}-CH~2~-CH-).

ESIMS (*m/z*): 439.2 (31.4 %).

### *2.1.4*. *2,2'*-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol) **(IV)** Yield 417.1 mg, 73 %, colour - Pale yellow, M.P. 178--180 °C {#sec2.1.4}

**FT-IR (KBr, cm**^**−1**^**):** 3467(νOH), 1730(νC = N), 1590(νN−H), 1562(νC = C), 1080(νC−N--C). ^**1**^**H NMR (CDCl**~**3**~**) (ppm) δ:** 13.82(s,Ar-OH,2H), 8.52(dd, J = 7.1Hz,J = 2.4Hz,2H), 7.95(dd, J = 6.3Hz,J = 3.1Hz,2H), 7.65(dd,J = 6.8Hz,J = 1.2Hz,2H), 7.26(S,2H), 6.83(dd,J = 7.3Hz,J = 3.1Hz,2H), 4.39(t,J = 4.5Hz,-CH~2~,2H), 3.70--3.72(m,J = 4.6Hz,-CH~,~1H), 2.45(s,-CH~3,~3H), 2.40(s,-CH~3~,3H), 2.37(q,J = 4.3Hz,-CH~2,~ 2H), 1.87--1.89(m, J = 4.1Hz,-CH~2,~2H), 1.02(t, J = 4.1Hz,-CH~3,~3H).

^**13**^**C NMR (CDCl**~**3**~**) (ppm) δ:** 175.2(−[C]{.ul}=N−), 170.7([C]{.ul}--O), 137.1--105.9(Ar-[C]{.ul}-), 135.0(-[C]{.ul}-X), 54.1(-N-[C]{.ul}-H), 41.7(−N--[C]{.ul}H~2~-), 34.6(HC--[C]{.ul}--CH~2~-), 29.4(H~3~C--[C]{.ul}--CH-), 14.4(-N=C--[C]{.ul}H~3~), 10.2(-[C]{.ul}-CH~2~-CH-).

ESIMS (*m/z*): 598.05 (48.6 %).

2.2. Characterization {#sec2.2}
---------------------

All synthesised products are confirmed by their characterization. In laboratory, thin layer chromatography (TLC) is used to check the purity of product. TLC was carried out on 0.25-mm E Merck gel plates (60F-254) and spot were visualized by UV light. Melting points were determined on a digital apparatus Koefler Banc. The elemental analysis was carried out by using Perkin-Elmer 240 elemental analyzer. The UV- Visible spectra were recorded in chloroform between 190-700 nm using UV-1800 series spectrophotometer with the light source wavelength 360 nm. A Perkin Elmer Spectrum one FT-IR spectrometer with the diffuse reflectance attachment (Miracle Attenuated Total Reflectance Attachment) at a 4 cm^−1^ resolution in the region 4000-600 cm^−1^ was employed to record the infrared spectrum to analyze the functional groups present in the Schiff bases compounds. NMR spectra were obtained with Bruker Avance III HD 300 operating at 300 MHz (1H), 50 MHz (13C) at 21 °C. Chemical shifts referenced to ext. TMS (1H, 13C). Coupling constants are given in Hz. Mass spectra were taken on LC-MS (ESI) mass or GC-MS mass spectrometer at 70 eV.

2.3. Biological activity {#sec2.3}
------------------------

### 2.3.1. Antibacterial activity (in vitro) {#sec2.3.1}

The synthesized Schiff bases **(I-IV)** were screened *in vitro* for their antibacterial activity, Kirby-Bauer method was followed for disc diffusion method. *In vitro* antibacterial activity was screened by using Mueller Hinton Agar (MHA) obtained from Himedia (Mumbai). The MHA plates were prepared by pouring 15 ml of molten media into sterile petriplates. The plates were allowed to solidify for 5 min and 0.1 % inoculums suspension was swabbed uniformly and the Inoculums were allowed to dry for 5 min. The concentration of compounds were set at (10 μg/disc) were loaded on 5 mm sterile individual discs. The loaded discs were placed on the surface of medium and the compound was allowed to diffuse for 5 min and the plates were kept for incubation at 37 °C for 24 h. Penicillin (10 μg/disc) was used as positive control. At the end of incubation, inhibition zones formed around the disc were measured with transparent ruler in millimetre.

### 2.3.2. Minimum inhibitory concentration (MIC) {#sec2.3.2}

The determination of minimum inhibitory concentration (MIC) were carried out by micro dilution method using serially diluted (2 fold) plant extract according to (National Committee for Clinical Laboratory Standards NCCLS, 2000). The crude extracts were reconstituted in 10 % v/v aqueous dimethyl sulfoxide (DMSO) at various concentrations of 1 mg/ml, 0.5 mg/ml, 0.25 mg/ml and 0.12.5 mg/ml respectively. 1.0 ml of extract and add 1.0 ml of nutrient broth were mixed in a test tube then 100 μL of an 24 h old active cultures of each of bacteria earlier adjusted at 10^6^ colony forming unit (CFU/mL) were added in each tube. Two control tubes were maintained for each test batch. These included antibiotic control (tube containing extract and growth media) and organism control (tube containing growth media and inoculums). The lowest concentration of the extract with no detectable bacterial growth (no turbidity) by visual inspection was considered as minimum inhibitory concentration (MIC).

### 2.3.3. Antioxidant activity {#sec2.3.3}

#### 2.3.3.1. 2, 2-Diphenyl-1- Picryl Hydrazyl (DPPH) assay {#sec2.3.3.1}

DPPH (2, 2, Diphenyl-1-Picryl Hydrazyl) radical scavenging assay was carried out as per kato *et al*, 1998 produces with slight modifications. 1ml ethanolic solution of different concentration of newly synthesized Schiff\'s bases was added to equal volume of 0.1mm ethanolic solution of DPPH. Above solutions were kept for incubation at room temp. The decreases in concentration of DPPH were measured by noting the absorbance at 517nm. Similar test was performed using ascorbic acid, as an internal standard, instead of Schiff\'s base.

#### 2.3.3.2. Hydroxyl radical scavenging assay {#sec2.3.3.2}

Hydroxyl radical scavenging activities were determined by the earlier reported method (Yu et al., 2004). The reaction cocktail contained 60 μl of 1 mm, Fecl~3~, 90 μl of 1 mM 1,10-phenanthroline, 2.4 ml of 0.2 M phosphate buffer (pH 7.8), 150 μl of 0.17 M H~2~O~2~, and 1.5 ml of various concentration of individual compound. Reaction mixture kept at room temperature for 5 min incubation and absorbance was measured at 560 nm using spectrophotometer. The α-Tocopherol was used a reference compound (see [Fig. 1](#fig1){ref-type="fig"}).Fig. 1Synthesis and structure of Schiff bases **(I-IV)**.Fig. 1

3. Result and discussion {#sec3}
========================

From various physical parameter and obtained instrumental data we have concluded that, the Schiff bases **(I-IV)** are coloured solid, partially soluble in ethanol but soluble in methanol, dichloromethane, DMSO, DMF, and CHCl~3.~ The purity of compounds was checked by TLC. From spectral data **(**UV-Vis, FT - IR, ^1^H NMR, ^13^C NMR and LCMS**)** we predict correct structure of Schiff bases **(I-IV).** All the synthesized compounds **(I-IV)** were screened for their antibacterial activity with MICs of 0.12, 0.25, 0.5 and 1 mg/ml against *E. coli* and *Salmonella Typhi* whereas antioxidant activity by DPPH (2, 2, Diphenyl-1-Picryl Hydrazyl) radical scavenging assay and Hydroxyl radical scavenging method. These are formulated in Tables [1](#tbl1){ref-type="table"}, [2](#tbl2){ref-type="table"}, and [3](#tbl3){ref-type="table"}.Table 1Antibacterial activity of given Schiff bases **(I-IV)**.Table 1Compounds*E. coli.Salmonella Typhi*Penicillin (10 μg/disc)**0912**I0506II1011III0708IV0805DMSO\-\-\--[^1]Table 2MICs of given Schiff bases **(I-IV)**.Table 2Code No. of CompoundName of pathogens*Escherichia coli* (mg/mL)*Salmonella Typhi* (mg/mL)1.00.50.250.121.00.50.250.12I**++++**-**+++**II**--------**III**--++--++**IV**--++++++**Penicillin (10 μg/mL)**-------+**[^2]Table 3Antioxidant activity of given Schiff bases **(I-IV)**.Table 3CompoundsDPPH (%)OH (%)Ascorbic Acid**85.42 ± 0.78**\--α- Tocopherol\--**82.50 ± 0.84**I74.28 ± 0.3670.77 ± 0.31II65.19 ± 0.1555.50 ± 0.15III62.89. ±0.5561.93 ± 0.15IV78.56 ± 0.4571.28 ± 0.17[^3]

3.1. Elemental analysis {#sec3.1}
-----------------------

The formations of the Schiff bases **(I-IV)** were confirmed by their elemental analysis. From elemental analysis we find out the carbon, hydrogen, nitrogen, oxygen and halogen contents of their structures. It is seen in [Table 4](#tbl4){ref-type="table"}.Table 4Analytical And Physical data of given Schiff bases **(I-IV).**Table 4CompoundMolecular formulaColourYield %M.P. (^o^C)Elemental Analysis (Cal.) (%)CHNX~(halogen)~IC~27~H~26~O~2~N~2~Yellow78153--15579.026.346.82\--IIC~27~H~24~O~2~N~2~Cl~2~Brown72158--16067.785.025.8514.64IIIC~29~H~30~O~2~N~2~Yellow75172--17477.676.696.25\--IVC~29~H~28~O~2~N~2~Br~2~Pale Yellow73178--18058.384.694.6926.84

3.2. Spectroscopic studies {#sec3.2}
--------------------------

### 3.2.1. UV-Vis. Analysis {#sec3.2.1}

The UV-Vis spectra of Schiff bases **(I-IV)** are presented in Figs. [2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"} respectively. The UV-Vis. spectra of four compounds were studied in polar solvent. The electronic absorption spectra of compounds **(I-IV)** showed bands at 345 nm, 360 nm, 345 nm and 354 nm due to n→ π\* transition of the C=N imine group. Here, in compound **II** & **IV** there is slightly increase in transition value of imine group this is due to presence of halogen group. The longer wavelength band over 400 nm showed that an intermolecular charge transfer interaction \[[@bib61], [@bib62]\].Fig. 2UV- Vis. Spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 2Fig. 3UV- Vis. Spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol).Fig. 3Fig. 4UV- Vis. Spectrum of 2, 2'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 4Fig. 5UV- Vis. Spectrum of 2, 2'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol).Fig. 5

### 3.2.2. FT-IR analysis {#sec3.2.2}

The IR spectra of Schiff bases **(I-IV)** synthesized are presented in Figs. [6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}, [8](#fig8){ref-type="fig"}, and [9](#fig9){ref-type="fig"} respectively. From [Table 5](#tbl5){ref-type="table"} it is clear that schiff bases **I** to **IV** are given strong bands at 1726, 1724, 1727 and 1730 cm^−1^ are due to (-C=N) stretching mode of the imine group respectively. The observation of phenolic ν(C--O) in range 1147--1386 cm^−1^ for these compounds it is the evidence for the existence of keto-amine form (N--O⋯H) intramolecular hydrogen bonding only in the solid state \[[@bib61]\]. Two C-X stretching vibrations are seen for compound **II** and **IV** at 806,875 cm^−1^ and 808,863 cm^−1^ respectively, it confirms that these halogens substituted at para position to the aromatic --OH group. It is clear that compounds **II** and **IV** are halogen substituted compounds at aromatic ring \[[@bib61], [@bib62]\]. The significant Infrared bands of these compounds are summarised in [Table 5](#tbl5){ref-type="table"}.Fig. 6FT-IR spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 6Fig. 7FT-IR spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol).Fig. 7Fig. 8FT-IR spectrum of 2, 2'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 8Fig. 9FT-IR spectrum of 2, 2'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol).Fig. 9Table 5Spectroscopic data (IR) of given Schiff bases **(I-IV)**.Table 5Compoundν(O--H)ν(CH)Arν(−CH = N−)δ(N--H)ν(C=C)ν(C--O)ν(C--N--C)ν(C−X)I34852910--28661726158715521147--13831022\--II33992927--28651724158515251149--13671072806,875III34852964--28751727159315621155--13461022\--IV34672962--28001730159015621149--13861080808, 863

### 3.2.3. ^1^H NMR analysis {#sec3.2.3}

The ^1^H NMR spectra of Schiffs bases **(I-IV)** are shown in Figs. [10](#fig10){ref-type="fig"}, [11](#fig11){ref-type="fig"}, [12](#fig12){ref-type="fig"}, and [13](#fig13){ref-type="fig"} respectively. The various observations are found by these spectral data and they are formulated in [Table 6](#tbl6){ref-type="table"}. In compound **I, II, III** and **IV** presence of singlet in between range of δ 13.50--14.02 ppm is due to phenolic --OH proton. In Comp. **II** the chloride atom present at para position to the aromatic hydroxyl group, it shows singlet at 14.02 ppm due to more acidic proton. Whereas comp. **IV** contains bromide atom at para position to the aromatic hydroxyl group, it shows singlet at 13.82 ppm due to moderate acidic proton. Presence of hydrogen bond between phenolic --OH and nitrogen atoms is stronger in comp. **II** than that of the comp. **IV** having weaker hydrogen bond between phenolic --OH and nitrogen atom. Presence of singlet at δ 2.47 and 2.50 ppm of 6H due to two --CH~3~ confirms formation of compound **I** and **II**. But in compound **III** and **IV** due to different environment they give two peaks. Also the appearance of ethyl group in compound **III** and **IV**, the Presence of quartet of --CH~3~ at δ1.02 and Presence of multiplet of --CH~2~ at δ1.82 and 1.89. The significant ^1^H NMR ppm values of these compounds are summarised in [Table 6](#tbl6){ref-type="table"}.Fig. 10^1^H NMR spectrum of 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 10Fig. 11^1^H NMR spectrum of 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol).Fig. 11Fig. 12^1^H NMR spectrum of 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 12Fig. 13^1^H NMR spectrum of 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol).Fig. 13Table 6Spectroscopic data (^1^*HNMR*) (δ) of the given Schiff bases **(I-IV).**Table 6GroupComp. IComp. IIComp.IIIComp. IVAr-O-[H]{.ul}13.5214.0213.5013.82Ar--[H]{.ul}8.50--6.858.53--6.848.50--6.808.52--6.83=N--[CH]{.ul}~2~--CH~2~--[CH]{.ul}~2~--N3.873.84\-\-\--N=C--[CH]{.ul}~3~2.472.502.44,2.402.45,2.40=N--CH~2~--[CH]{.ul}~2~--CH~2~--N2.312.33\-\-\--![](fx1.gif)\-\-\--3.693.72=N--[CH]{.ul}~2~--CH~2~--CH\-\-\-\--4.324.39=N--CH~2~--[CH]{.ul}~2~--CH\-\-\-\--2.212.37CH~3~--[CH]{.ul}~2~\-\-\-\--1.821.89[CH]{.ul}~3~--CH~2~\-\-\-\--1.021.02

### 3.2.4. ^13^C NMR analysis {#sec3.2.4}

The ^13^C NMR spectra of Schiffs bases **(I-IV)** are shown in Figs. [14](#fig14){ref-type="fig"}, [15](#fig15){ref-type="fig"}, [16](#fig16){ref-type="fig"}, and [17](#fig17){ref-type="fig"} respectively. The various observations are seen by these spectral data and they are formulated in [Table 7](#tbl7){ref-type="table"}. From the table it is shown that Compounds **I** to **IV** gives signals at δ 175.16, 175.20, 175.19 and 175.20 due to imine carbon, the presence of signals at δ 171.65, 171.68, 171.13 and 170.70 due to carbon bearing oxygen respectively. It is also clear that the compounds **II** and **IV** shows peak at δ 132.37 and 135.01 due to carbon bearing to halogen group. The compounds **III** and **IV** signal shows at δ 54.11 and 54.12 due to -N-[C]{.ul}-H group, at δ 29.43 and 29.36 due to CH3--[C]{.ul}--CH- group whereas δ 10.27 and 10.24 due to -[C]{.ul}-CH~2~-CH- group. From [Table 7](#tbl7){ref-type="table"}*,* it confirms compounds **I** and **III** are have no halogen substituted carbon, it is also clear that the compounds **III** and **IV** are having presence of -N-[C]{.ul}-H, CH3--[C]{.ul}--CH-, -[C]{.ul}-CH~2~-CH- groups. The significant ^13^C NMR ppm values of these compounds are summarised in [Table 7](#tbl7){ref-type="table"}.Fig. 14^13^C NMR spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 14Fig. 15^13^C NMR spectrum of 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol).Fig. 15Fig. 16^13^C NMR spectrum of 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 16Fig. 17^13^C NMR spectrum of 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol).Fig. 17Table 7Spectroscopic data (^13^*CNMR*) (δ) of the given Schiff bases **(I-IV).**Table 7GroupComp. IComp. IIComp.IIIComp. IV-[C]{.ul}=N-175.16175.20175.19175.23-[C]{.ul}-O-H171.65171.68171.13170.70Ar-[C]{.ul}-137.10--108.79137.02--108.19137.22--106.53137.14--105.96C-X\--132.37\--135.01-N-[C]{.ul}-H\-\-\--54.1154.12-N- [CH]{.ul}~2~[-]{.ul}42.2542.1041.8341.73HC-[C]{.ul}-CH~2~-29.4029.2334.5934.60CH3--[C]{.ul}--CH\-\-\-\--29.4329.36-N=C--[C]{.ul}H~3~14.4714.4014.3714.37-[C]{.ul}-CH~2~-CH\-\-\-\--10.2710.24

### 3.2.5. LCMS analysis {#sec3.2.5}

The LCMS spectra of Schiff bases **(I-IV)** are shown in Figs. [18](#fig18){ref-type="fig"}, [19](#fig19){ref-type="fig"}, [20](#fig20){ref-type="fig"}, and [21](#fig21){ref-type="fig"} respectively. Presence of M+1 signal at m/z 411 and m/z 439 confirms formation of Schiffs bases **I** and **III** respectively. Similarly, the appearance of M-2Cl signals at m/z 409 and M-2Br signal at m/z 437 as base peak also confirms formation of compounds **II** and **IV** \[[@bib62], [@bib63]\].Fig. 18Mass spectrum of 2, 2'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 18Fig. 19Mass spectrum of 2,2\'-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-chloronaphthalen-1-ol).Fig. 19Fig. 20Mass spectrum of 2, 2'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(naphthalen-1-ol).Fig. 20Fig. 21Mass spectrum of 2,2\'-((pentane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-1-ylidene))bis(4-bromonaphthalen-1-ol).Fig. 21

3.3. Biological activity {#sec3.3}
------------------------

### 3.3.1. Antibacterial activity (in vitro) {#sec3.3.1}

Schiff bases **(I-IV)** were evaluated for their antibacterial potencies against pathogenic gram negative bacteria, *E. coli* and *Salmonella Typhi* using penicillin as positive control and solvent DMSO as a negative control and the results are represented in [Table 1](#tbl1){ref-type="table"}. Although no define structure-activity relationship could be determined, some conclusions on structural changes that may influence the antibacterial activity can be drawn by the comparison among the structure of compound with different activity (see Figs. [22](#fig22){ref-type="fig"} and [23](#fig23){ref-type="fig"}).Fig. 22Graphical Representation of Antibacterial activity of synthesized Schiff bases **(I-IV)**.Fig. 22Fig. 23Graphical Representation of Antioxidant activity of synthesized Schiff bases **(I-IV)**.Fig. 23

The biological activity is depending on hydrogen bonding present in that molecule. From the spectral data it confirms, comp. **II** having stronger hydrogen bonding, it is responsible to show good antibacterial activity against *E. coli* and *Salmonella Typhi.* comp. **IV** having moderate hydrogen bonding, hence it shows moderate antibacterial activity against *E. coli* while it shows less antibacterial activity against *Salmonella Typhi.* Similarly, compound **I** shows less antibacterial activity against *E. coli* and *Salmonella Typhi.*

The hydroxyl group adjacent to imine group is very common feature in Schiff bases; it participates to stabilize by a hydrogen bond the predominant structure of the Schiff bases. Therefore, the hydroxyl substituent may be important group for structure stability.

A hydroxyl group in position 4 is halogenated the Schiff base is more active. When the free hydroxyl group in position 4 Schiff bases not more active. Here, compounds **II** and **IV** inhibited effectively *E. coli,* it may be because of halogen group present at position 4 to the hydroxyl group.

#### 3.3.1.1. Minimum inhibitory concentration (MIC) {#sec3.3.1.1}

The minimum inhibitory concentration of synthesized schiff bases were carried out at different concentration i.e. 1.0, 0.5, 0.25, 0.12 mg/ml the result of MIC were given in [Table 3](#tbl3){ref-type="table"}. From table it is clear that, the Comp. **II** shows a good inhibition at minimum concentration (0.12 mg/ml) against both organisms. The comp. **III** shows a good inhibition at minimum concentration (0.50 mg/ml) against both organisms. Compound **IV** shows good inhibition at minimum concentration (0.50 mg/ml) against *E. coli.* Comp. **III** and **IV** shows good inhibition at minimum concentration (1.0 mg/ml) against *E. coli.* Comp. **I** and **III** shows good inhibition at minimum concentration (1.0 mg/ml) against *Salmonella typhi.*

Comparative study also revealed that the halogen substituent with less number carbon chain has good inhibition against *E. coli* and *Salmonella Typhi.* Inhibition will be reduces if carbon chain extended on halogen substituted compound.

### 3.3.2. Antioxidant activity (in vitro) {#sec3.3.2}

Schiff bases **(I-IV)** were evaluated for their radical scavenging capacity (antioxidant activity) by DPPH and hydroxyl radical scavenging assay using Ascorbic acid and α-Tocopherol as internal standard respectively, results are showed in [Table 3](#tbl3){ref-type="table"}. In both methods used, the compounds **I** and **IV** are exhibiting higher activity than **II** and **III.** It may be due to compound **I** is with free hydroxyl group in position 4 and presence of 1,3 propane diamine group also compound **IV** is with halogenated hydroxyl group in position 4 and 1,3 pentane diamines.

Comparative study also revealed that the halogen substituent with extended carbon chain has good antioxidant activity. Activity will be reduces if free hydroxyl group and halogenated hydroxyl group in position 4 with less number of carbon chain.

4. Conclusion {#sec4}
=============

The current study describes the synthesis of four novel Schiff bases **(I-IV)** were identified by using melting point, UVvis., IR, ^1^H NMR, ^13^C NMR and LCMS.

It is also assayed for antibacterial and antioxidant activities. Antibacterial activity was studied against Gram-negative pathogenic bacteria with MICs of 0.12, 0.25, 0.5 and 1 mg/ml against *E. coli* and *Salmonella Typhi*. Antioxidant activity was studied by DPPH and hydroxyl radical method.

Among these schiff bases, compound **II** and **IV** are having stronger hydrogen bonding than compound **I** and **III**. It concludes that compound **II** shows better antibacterial activity against *E. coli* and *Salmonella Typhi* and compound **IV** exhibits better radical scavenging activity by both DPPH and hydroxyl radical method. These studies reveal the antibacterial and antioxidant potency of Schiff bases of 1-hydroxyacetonaphthone.
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[^1]: Bold showing reference drug numbers.

[^2]: The positive sign (+) indicate growth on plate; negative sign (--) indicate no growth on plate.

[^3]: Bold showing reference drug numbers.
